Loading…

A 2b receptor mediates adenosine inhibition of taurine efflux from pituicytes

Background information . Recent work suggests that part of the control of vasopressin output is mediated by taurine released from pituicytes, the astroglial cells of the neurohypophysis. Taurine release, in turn, is stimulated by hypotonic conditions and by vasopressin itself. As adenosine is genera...

Full description

Saved in:
Bibliographic Details
Published in:Biology of the cell 2007-08, Vol.99 (8), p.445-454
Main Authors: Pierson, Patricia M., Peteri‐Brunbäck, Brigitta, Pisani, Didier F., Abbracchio, Maria Pia, Mienville, Jean‐Marc, Rosso, Lia
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c768-8453013efc0f4fce675a0b8d72b28ca6040cb771b9b20ded78e59f60f0df6b7e3
cites cdi_FETCH-LOGICAL-c768-8453013efc0f4fce675a0b8d72b28ca6040cb771b9b20ded78e59f60f0df6b7e3
container_end_page 454
container_issue 8
container_start_page 445
container_title Biology of the cell
container_volume 99
creator Pierson, Patricia M.
Peteri‐Brunbäck, Brigitta
Pisani, Didier F.
Abbracchio, Maria Pia
Mienville, Jean‐Marc
Rosso, Lia
description Background information . Recent work suggests that part of the control of vasopressin output is mediated by taurine released from pituicytes, the astroglial cells of the neurohypophysis. Taurine release, in turn, is stimulated by hypotonic conditions and by vasopressin itself. As adenosine is generated from ATP co‐released with vasopressin, it appeared important to study its effects on taurine efflux from pituicytes. Results . We measured radioactive efflux from cultured pituicytes and whole neurohypophyses pre‐loaded with [ 3 H]taurine. Cultured pituicytes were also used to study adenosine‐receptor mRNA expression. Taurine efflux elicited by hypotonic shocks is ∼30–50% smaller in the presence of 10 μM adenosine or 1 μM NECA (5′‐ N ‐ethylcarboxamidoadenosine). Both compounds also inhibited basal efflux in a manner that was not immediately reversible. Agonists of the adenosine A 1 ‐, A 2a ‐ or A 3 ‐receptor subtypes have no relevant effect on basal taurine release, and the A 1 ‐receptor antagonist DPCPX (8‐cyclopentyl‐1,3‐dipropylxanthine) has no effect on the inhibition of release by NECA. In turn, the A 2b ‐receptor antagonists MRS 1706 { N ‐(4‐acetylphenyl)‐2‐[4‐(2,3,6,7‐tetrahydro‐2,6‐dioxo‐1,3‐dipropyl‐1 H ‐purin‐8‐yl)phenoxy]acetamide} or alloxazine partially reverse the inhibition of basal or hypotonicity‐evoked efflux by NECA. Both A 1 ‐ and A 2b ‐receptor mRNAs are expressed in pituicytes, which is consistent with an A 1 ‐receptor‐mediated effect on cell morphology and an A 2b ‐receptor‐mediated effect on taurine release. Forskolin and dibutyryl cAMP mimic the inhibitory effects of purinergics on basal taurine efflux, and the adenylate cyclase inhibitor DDA (2′,5′‐dideoxyadenosine) partially reverses the inhibition of the hypotonic response by NECA. Conclusions . Our results suggest that purinergic inhibition of taurine efflux from pituicytes operates through A 2b receptors coupled to intracellular cAMP increase. They point to a possible modulation of neurohypophysial hormone output by endogenous adenosine released in either physiological or pathological situations.
doi_str_mv 10.1042/BC20070028
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1042_BC20070028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1042_BC20070028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c768-8453013efc0f4fce675a0b8d72b28ca6040cb771b9b20ded78e59f60f0df6b7e3</originalsourceid><addsrcrecordid>eNpFkM1KxDAYRYMoWEc3PkHWQvVLmjbpciz-wYibWbgr-fmCkWlTkhact9ei4OrChXu4HEKuGdwyEPzuvuMAEoCrE1Iw2aiy4vz9lBTAhSpFC3BOLnL-BADRqrogr1vKDU1ocZpjogO6oGfMVDscYw4j0jB-BBPmEEcaPZ31ktYWvT8sX9SnONApzEuwx5_ZJTnz-pDx6i83ZP_4sO-ey93b00u33ZV2vaREXQGr0FvwwltsZK3BKCe54crqBgRYIyUzreHg0EmFdesb8OB8YyRWG3Lzi7Up5pzQ91MKg07HnkG_euj_PVTfOlNQow</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A 2b receptor mediates adenosine inhibition of taurine efflux from pituicytes</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Pierson, Patricia M. ; Peteri‐Brunbäck, Brigitta ; Pisani, Didier F. ; Abbracchio, Maria Pia ; Mienville, Jean‐Marc ; Rosso, Lia</creator><creatorcontrib>Pierson, Patricia M. ; Peteri‐Brunbäck, Brigitta ; Pisani, Didier F. ; Abbracchio, Maria Pia ; Mienville, Jean‐Marc ; Rosso, Lia</creatorcontrib><description>Background information . Recent work suggests that part of the control of vasopressin output is mediated by taurine released from pituicytes, the astroglial cells of the neurohypophysis. Taurine release, in turn, is stimulated by hypotonic conditions and by vasopressin itself. As adenosine is generated from ATP co‐released with vasopressin, it appeared important to study its effects on taurine efflux from pituicytes. Results . We measured radioactive efflux from cultured pituicytes and whole neurohypophyses pre‐loaded with [ 3 H]taurine. Cultured pituicytes were also used to study adenosine‐receptor mRNA expression. Taurine efflux elicited by hypotonic shocks is ∼30–50% smaller in the presence of 10 μM adenosine or 1 μM NECA (5′‐ N ‐ethylcarboxamidoadenosine). Both compounds also inhibited basal efflux in a manner that was not immediately reversible. Agonists of the adenosine A 1 ‐, A 2a ‐ or A 3 ‐receptor subtypes have no relevant effect on basal taurine release, and the A 1 ‐receptor antagonist DPCPX (8‐cyclopentyl‐1,3‐dipropylxanthine) has no effect on the inhibition of release by NECA. In turn, the A 2b ‐receptor antagonists MRS 1706 { N ‐(4‐acetylphenyl)‐2‐[4‐(2,3,6,7‐tetrahydro‐2,6‐dioxo‐1,3‐dipropyl‐1 H ‐purin‐8‐yl)phenoxy]acetamide} or alloxazine partially reverse the inhibition of basal or hypotonicity‐evoked efflux by NECA. Both A 1 ‐ and A 2b ‐receptor mRNAs are expressed in pituicytes, which is consistent with an A 1 ‐receptor‐mediated effect on cell morphology and an A 2b ‐receptor‐mediated effect on taurine release. Forskolin and dibutyryl cAMP mimic the inhibitory effects of purinergics on basal taurine efflux, and the adenylate cyclase inhibitor DDA (2′,5′‐dideoxyadenosine) partially reverses the inhibition of the hypotonic response by NECA. Conclusions . Our results suggest that purinergic inhibition of taurine efflux from pituicytes operates through A 2b receptors coupled to intracellular cAMP increase. They point to a possible modulation of neurohypophysial hormone output by endogenous adenosine released in either physiological or pathological situations.</description><identifier>ISSN: 0248-4900</identifier><identifier>EISSN: 1768-322X</identifier><identifier>DOI: 10.1042/BC20070028</identifier><language>eng</language><ispartof>Biology of the cell, 2007-08, Vol.99 (8), p.445-454</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c768-8453013efc0f4fce675a0b8d72b28ca6040cb771b9b20ded78e59f60f0df6b7e3</citedby><cites>FETCH-LOGICAL-c768-8453013efc0f4fce675a0b8d72b28ca6040cb771b9b20ded78e59f60f0df6b7e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Pierson, Patricia M.</creatorcontrib><creatorcontrib>Peteri‐Brunbäck, Brigitta</creatorcontrib><creatorcontrib>Pisani, Didier F.</creatorcontrib><creatorcontrib>Abbracchio, Maria Pia</creatorcontrib><creatorcontrib>Mienville, Jean‐Marc</creatorcontrib><creatorcontrib>Rosso, Lia</creatorcontrib><title>A 2b receptor mediates adenosine inhibition of taurine efflux from pituicytes</title><title>Biology of the cell</title><description>Background information . Recent work suggests that part of the control of vasopressin output is mediated by taurine released from pituicytes, the astroglial cells of the neurohypophysis. Taurine release, in turn, is stimulated by hypotonic conditions and by vasopressin itself. As adenosine is generated from ATP co‐released with vasopressin, it appeared important to study its effects on taurine efflux from pituicytes. Results . We measured radioactive efflux from cultured pituicytes and whole neurohypophyses pre‐loaded with [ 3 H]taurine. Cultured pituicytes were also used to study adenosine‐receptor mRNA expression. Taurine efflux elicited by hypotonic shocks is ∼30–50% smaller in the presence of 10 μM adenosine or 1 μM NECA (5′‐ N ‐ethylcarboxamidoadenosine). Both compounds also inhibited basal efflux in a manner that was not immediately reversible. Agonists of the adenosine A 1 ‐, A 2a ‐ or A 3 ‐receptor subtypes have no relevant effect on basal taurine release, and the A 1 ‐receptor antagonist DPCPX (8‐cyclopentyl‐1,3‐dipropylxanthine) has no effect on the inhibition of release by NECA. In turn, the A 2b ‐receptor antagonists MRS 1706 { N ‐(4‐acetylphenyl)‐2‐[4‐(2,3,6,7‐tetrahydro‐2,6‐dioxo‐1,3‐dipropyl‐1 H ‐purin‐8‐yl)phenoxy]acetamide} or alloxazine partially reverse the inhibition of basal or hypotonicity‐evoked efflux by NECA. Both A 1 ‐ and A 2b ‐receptor mRNAs are expressed in pituicytes, which is consistent with an A 1 ‐receptor‐mediated effect on cell morphology and an A 2b ‐receptor‐mediated effect on taurine release. Forskolin and dibutyryl cAMP mimic the inhibitory effects of purinergics on basal taurine efflux, and the adenylate cyclase inhibitor DDA (2′,5′‐dideoxyadenosine) partially reverses the inhibition of the hypotonic response by NECA. Conclusions . Our results suggest that purinergic inhibition of taurine efflux from pituicytes operates through A 2b receptors coupled to intracellular cAMP increase. They point to a possible modulation of neurohypophysial hormone output by endogenous adenosine released in either physiological or pathological situations.</description><issn>0248-4900</issn><issn>1768-322X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpFkM1KxDAYRYMoWEc3PkHWQvVLmjbpciz-wYibWbgr-fmCkWlTkhact9ei4OrChXu4HEKuGdwyEPzuvuMAEoCrE1Iw2aiy4vz9lBTAhSpFC3BOLnL-BADRqrogr1vKDU1ocZpjogO6oGfMVDscYw4j0jB-BBPmEEcaPZ31ktYWvT8sX9SnONApzEuwx5_ZJTnz-pDx6i83ZP_4sO-ey93b00u33ZV2vaREXQGr0FvwwltsZK3BKCe54crqBgRYIyUzreHg0EmFdesb8OB8YyRWG3Lzi7Up5pzQ91MKg07HnkG_euj_PVTfOlNQow</recordid><startdate>200708</startdate><enddate>200708</enddate><creator>Pierson, Patricia M.</creator><creator>Peteri‐Brunbäck, Brigitta</creator><creator>Pisani, Didier F.</creator><creator>Abbracchio, Maria Pia</creator><creator>Mienville, Jean‐Marc</creator><creator>Rosso, Lia</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200708</creationdate><title>A 2b receptor mediates adenosine inhibition of taurine efflux from pituicytes</title><author>Pierson, Patricia M. ; Peteri‐Brunbäck, Brigitta ; Pisani, Didier F. ; Abbracchio, Maria Pia ; Mienville, Jean‐Marc ; Rosso, Lia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c768-8453013efc0f4fce675a0b8d72b28ca6040cb771b9b20ded78e59f60f0df6b7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pierson, Patricia M.</creatorcontrib><creatorcontrib>Peteri‐Brunbäck, Brigitta</creatorcontrib><creatorcontrib>Pisani, Didier F.</creatorcontrib><creatorcontrib>Abbracchio, Maria Pia</creatorcontrib><creatorcontrib>Mienville, Jean‐Marc</creatorcontrib><creatorcontrib>Rosso, Lia</creatorcontrib><collection>CrossRef</collection><jtitle>Biology of the cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pierson, Patricia M.</au><au>Peteri‐Brunbäck, Brigitta</au><au>Pisani, Didier F.</au><au>Abbracchio, Maria Pia</au><au>Mienville, Jean‐Marc</au><au>Rosso, Lia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A 2b receptor mediates adenosine inhibition of taurine efflux from pituicytes</atitle><jtitle>Biology of the cell</jtitle><date>2007-08</date><risdate>2007</risdate><volume>99</volume><issue>8</issue><spage>445</spage><epage>454</epage><pages>445-454</pages><issn>0248-4900</issn><eissn>1768-322X</eissn><abstract>Background information . Recent work suggests that part of the control of vasopressin output is mediated by taurine released from pituicytes, the astroglial cells of the neurohypophysis. Taurine release, in turn, is stimulated by hypotonic conditions and by vasopressin itself. As adenosine is generated from ATP co‐released with vasopressin, it appeared important to study its effects on taurine efflux from pituicytes. Results . We measured radioactive efflux from cultured pituicytes and whole neurohypophyses pre‐loaded with [ 3 H]taurine. Cultured pituicytes were also used to study adenosine‐receptor mRNA expression. Taurine efflux elicited by hypotonic shocks is ∼30–50% smaller in the presence of 10 μM adenosine or 1 μM NECA (5′‐ N ‐ethylcarboxamidoadenosine). Both compounds also inhibited basal efflux in a manner that was not immediately reversible. Agonists of the adenosine A 1 ‐, A 2a ‐ or A 3 ‐receptor subtypes have no relevant effect on basal taurine release, and the A 1 ‐receptor antagonist DPCPX (8‐cyclopentyl‐1,3‐dipropylxanthine) has no effect on the inhibition of release by NECA. In turn, the A 2b ‐receptor antagonists MRS 1706 { N ‐(4‐acetylphenyl)‐2‐[4‐(2,3,6,7‐tetrahydro‐2,6‐dioxo‐1,3‐dipropyl‐1 H ‐purin‐8‐yl)phenoxy]acetamide} or alloxazine partially reverse the inhibition of basal or hypotonicity‐evoked efflux by NECA. Both A 1 ‐ and A 2b ‐receptor mRNAs are expressed in pituicytes, which is consistent with an A 1 ‐receptor‐mediated effect on cell morphology and an A 2b ‐receptor‐mediated effect on taurine release. Forskolin and dibutyryl cAMP mimic the inhibitory effects of purinergics on basal taurine efflux, and the adenylate cyclase inhibitor DDA (2′,5′‐dideoxyadenosine) partially reverses the inhibition of the hypotonic response by NECA. Conclusions . Our results suggest that purinergic inhibition of taurine efflux from pituicytes operates through A 2b receptors coupled to intracellular cAMP increase. They point to a possible modulation of neurohypophysial hormone output by endogenous adenosine released in either physiological or pathological situations.</abstract><doi>10.1042/BC20070028</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0248-4900
ispartof Biology of the cell, 2007-08, Vol.99 (8), p.445-454
issn 0248-4900
1768-322X
language eng
recordid cdi_crossref_primary_10_1042_BC20070028
source Wiley-Blackwell Read & Publish Collection
title A 2b receptor mediates adenosine inhibition of taurine efflux from pituicytes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A28%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%202b%20receptor%20mediates%20adenosine%20inhibition%20of%20taurine%20efflux%20from%20pituicytes&rft.jtitle=Biology%20of%20the%20cell&rft.au=Pierson,%20Patricia%20M.&rft.date=2007-08&rft.volume=99&rft.issue=8&rft.spage=445&rft.epage=454&rft.pages=445-454&rft.issn=0248-4900&rft.eissn=1768-322X&rft_id=info:doi/10.1042/BC20070028&rft_dat=%3Ccrossref%3E10_1042_BC20070028%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c768-8453013efc0f4fce675a0b8d72b28ca6040cb771b9b20ded78e59f60f0df6b7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true